Search results
JPMorgan Chase & Co. Raises Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $170.00
ETF DAILY NEWS· 5 days agoAscendis Pharma A/S (NASDAQ:ASND – Free Report) had its price objective upped by JPMorgan Chase & Co. from $167.00 to $170.00 in a research note published ...
10 best affordable online therapy providers for 2024
Yahoo Life Shopping· 3 days agoMore resources are available at thetrevorproject.org. What to consider when looking for an online mental health provider Choosing an online therapy...
Black Boy, 12, Is 1st Person Ever To Receive Groundbreaking Sickle Cell Gene Therapy Treatment
Black America Web· 4 days agoLast Wednesday, Kendric Cromer, a 12-year-old Black patient from the suburbs of Washington, D.C.,...
ATI Physical Therapy Inc (ATIP) (Q1 2024) Earnings Call Transcri
Guru Focus· 5 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Employee retention has improved, with a notable decrease in clinician turnover rate to 16% ...
Celebrities say it's a shortcut to more energy, but does IV therapy really deliver?
Palm Beach Daily News via Yahoo News· 3 days agoLast month, while out walking her 3-year-old Yorkie, she noticed that a new business ― Prime IV ―...
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 1 day agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
High prices for new diabetes drugs are reason for alarm
Futurity· 4 days agoThe implications of high prices for new diabetes and obesity therapies are alarming, according to...
AstraZeneca ups stake in Cellectis in latest cell therapy bet
BioPharma Dive via Yahoo Finance· 4 days agoThe British drugmaker, which has made genetic medicine a larger priority of late, added $140 million...
Extreme sports don't take a toll on longevity
UPI· 3 hours agoThe first 200 athletes to run a mile in under 4 minutes actually outlived the general population by nearly five years on average, according to results...
Earnings call: Oncolytics Biotech details progress in cancer studies By Investing.com
Investing.com· 5 hours agoOncolytics Biotech Inc. (NASDAQ:ONCY) shared promising updates on their cancer research and clinical...